Literature DB >> 2577189

Biological basis for chemohormonal therapy for prostatic cancer.

J T Isaacs, N Kyprianou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2577189     DOI： 10.1007/978-1-4613-1595-7_10

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  3 in total

1.  The beta-catenin binding protein ICAT modulates androgen receptor activity.

Authors:  Ming Zhuo; Chunfang Zhu; JingLucy Sun; William I Weis; Zijie Sun
Journal:  Mol Endocrinol       Date:  2011-09-01

2.  Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion.

Authors:  Nitu Bansal; Stephani Davis; Irina Tereshchenko; Tulin Budak-Alpdogan; Hua Zhong; Mark N Stein; Isaac Yi Kim; Robert S Dipaola; Joseph R Bertino; Hatem E Sabaawy
Journal:  Prostate       Date:  2013-10-24       Impact factor: 4.104

3.  A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells.

Authors:  Tzu-Huey Li; Hongjuan Zhao; Yue Peng; Jason Beliakoff; James D Brooks; Zijie Sun
Journal:  Nucleic Acids Res       Date:  2007-04-10       Impact factor: 16.971
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.